Home » Stocks » NARI

Inari Medical, Inc. (NARI)

Stock Price: $103.39 USD -1.66 (-1.58%)
Updated Apr 19, 2021 2:36 PM EDT - Market open
Market Cap 5.20B
Revenue (ttm) 139.67M
Net Income (ttm) 13.79M
Shares Out 49.50M
EPS (ttm) 0.27
PE Ratio 382.93
Forward PE 10,000.00
Dividend n/a
Dividend Yield n/a
Trading Day April 19
Last Price $103.39
Previous Close $105.05
Change ($) -1.66
Change (%) -1.58%
Day's Open 103.53
Day's Range 101.06 - 104.00
Day's Volume 283,006
52-Week Range 39.55 - 127.42

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

IRVINE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives...

2 weeks ago - GlobeNewsWire

Industry trends could support massive gains for shareholders over the next 10 years.

Other stocks mentioned: FLGT, TDOC
2 weeks ago - The Motley Fool

Even if the bullishness fades, the prospects for these companies have never been better.

Other stocks mentioned: FVRR, SE
3 weeks ago - The Motley Fool

The economy is poised to rebound. Many mutual funds are betting big on cyclical stocks.

Other stocks mentioned: CHGG, IAC
3 weeks ago - Investors Business Daily

If you are following the crowd, you might miss these disruptive companies.

Other stocks mentioned: FLGT
3 weeks ago - The Motley Fool

As bond yields finally drop and tech stocks climb, the deep learning algorithms at Q.ai have crunched the data to give you today's best short plays.

Other stocks mentioned: LAUR, SAVE, ZVO
4 weeks ago - Forbes

The clot-removing device maker is nearly perfect, and it's priced like it.

1 month ago - The Motley Fool

I'd increase my stakes in two small caps that I already own.

Other stocks mentioned: FOUR
1 month ago - The Motley Fool

IRVINE, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives ...

1 month ago - GlobeNewsWire

These are the small-cap stocks with the best value, fastest growth, and most momentum for March 2021.

Other stocks mentioned: APPS, CYH, NVAX, RVP, TBBK, VERI, VHC ...
1 month ago - Investopedia

IRVINE, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...

1 month ago - GlobeNewsWire

How have these big healthcare IPOs been doing?

Other stocks mentioned: AMWL, GDRX
1 month ago - The Motley Fool

OptimizeRx and Inari Medical are both crushing the market right now.

Other stocks mentioned: OPRX
2 months ago - The Motley Fool

IRVINE, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...

2 months ago - GlobeNewsWire

IRVINE, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives o...

2 months ago - GlobeNewsWire

IRVINE, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives o...

3 months ago - GlobeNewsWire

Inari Medical continues to live up to expectations, showing very solid growth and strong margins. I like the business a lot, yet have not initiated a position yet.

5 months ago - Seeking Alpha

US IPO market activity is picking back up ahead of the Thanksgiving holiday, with six IPOs scheduled to raise $3.4 billion in the week ahead. Biotech research product provider Maravai LifeSciences plans...

Other stocks mentioned: FHTX, GHLD, MCFE, MSP, SLQT
5 months ago - Seeking Alpha

There's good reason to think these young stocks have bright futures ahead.

Other stocks mentioned: ISRG
5 months ago - The Motley Fool

IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...

5 months ago - GlobeNewsWire

Inari Medical, Inc. (NARI) CEO Bill Hoffman on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

IRVINE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...

5 months ago - GlobeNewsWire

IRVINE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...

5 months ago - GlobeNewsWire

IRVINE, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) announced today that its management team will participate at the Canaccord Genuity Virtual MedTech & Diagno...

5 months ago - GlobeNewsWire

IRVINE, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced it will release financial results for the third quarter of 2020 after market close on Thurs...

5 months ago - GlobeNewsWire

These fast-growing medical device companies could outperform the S&P 500 over the next several years.

Other stocks mentioned: DXCM
5 months ago - The Motley Fool

IRVINE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the liv...

6 months ago - GlobeNewsWire

IRVINE, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the live...

7 months ago - GlobeNewsWire

IRVINE, Calif., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives...

7 months ago - GlobeNewsWire

Inari Medical, Inc. (NARI) CEO Bill Hoffman on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Hot IPO stock Inari Medical late Tuesday reported earnings and sales that beat expectations, but in the regular session shares reversed after hitting an all-time high for a third straight day. The post ...

8 months ago - Investors Business Daily

IRVINE, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the live...

8 months ago - GlobeNewsWire

IRVINE, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced the company will be participating in the upcoming Canaccord Genuity 40th Annual Virtual G...

8 months ago - GlobeNewsWire

IRVINE, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced it will release financial results for the second quarter of 2020 after market close on Tu...

8 months ago - GlobeNewsWire

Its medical devices offer promising clinical benefits over the competition.

10 months ago - The Motley Fool

IRVINE, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives...

10 months ago - GlobeNewsWire

Shares of Inari Medical Inc. NARI, +114.07% rocketed out of the gate Friday, as they opened for trading at prices that were more than double the initial public offering price.

10 months ago - Market Watch

Inari Medical Inc. increased that number of shares it was selling in its initial public offering, which priced late Thursday above the expected range.

10 months ago - Market Watch

About NARI

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.

Industry
Medical Devices
IPO Date
May 22, 2020
Stock Exchange
NASDAQ
Ticker Symbol
NARI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for Inari Medical stock is "Buy." The 12-month stock price forecast is 127.67, which is an increase of 23.48% from the latest price.

Price Target
$127.67
(23.48% upside)
Analyst Consensus: Buy